Biden Aims for 100 Million COVID Vaccinations in First 100 Days
It will not be an easy task
Medicine874 articles archived since 1845
The Second-Generation COVID Vaccines Are Coming
After Pfizer and Moderna, a slew of other candidates could fill gaps in efficacy, production, or distribution
Vaccines Need Not Completely Stop COVID Transmission to Curb the Pandemic
Lessons from other viruses show that even if vaccines don’t completely stop disease spread, they can still successfully contain it
The Remaining COVID-19 Journey
With a vaccine in limited availability, many still need medicines to keep the virus at bay
Should We Change COVID Vaccine Doses to Reach More People? What the Data Say
Scientists are debating whether to delay, skip or halve doses. But untested tweaks could shake public confidence
What Is Chronic Kidney Disease, and How Might It Affect You?
In the U.S., a third of Americans are at risk of chronic kidney disease, and age is a major factor. More than half of Americans older than 75 are thought to have some sort of kidney damage...
We Must Find Ways to Detect Cancer Much Earlier
The job of the oncologist of the future will be to prevent and treat the emergence of disease
The Best Evidence for How to Overcome COVID Vaccine Fears
Social science offers valuable lessons about ways to convince those who are hesitant about the shots
New COVID Vaccines Need Absurd Amounts of Material and Labor
Companies are scrambling to obtain supplies for hundreds of millions of doses of a type of vaccine that has never been made at this scale before
The U.K. Coronavirus Mutation Is Worrying but Not Terrifying
There is evidence the new variant could be more transmissible, yet vaccines work very well against it
Moderna COVID Vaccine Becomes Second to Get U.S. Authorization
Two RNA vaccines will be useful as U.S. infections surge, but the speedy authorizations complicate clinical trials
Profit and Loss: America on Dialysis
Kidney disease affects millions of Americans, but corporate capture of dialysis, along with disparities in treatment and transplant access, mean that not everyone’s journey is the same...
Few Kidney Patients Can Access Palliative Care or Hospice—Why?
Treatments that reduce suffering and incorporate patient values aren’t common in kidney disease care. That’s changing
The Lifesaving Potential of Less Than Perfect Donor Kidneys
Demand for healthy kidneys has long outstripped supply. But better testing and treatment are expanding the donor pool
For Black and Brown Kidney Patients, There Are Higher Hurdles to Care
Minority patients are diagnosed later, stay on dialysis longer and are added to transplant lists less quickly. Why?
A Nurse’s Message about the COVID-19 Vaccine
Nurse Kristen Choi says health care providers need to better educate patients about possible side effects from the COVID-19 vaccine. Christopher Intagliata reports.
Should Your Kidney Doctor Have a Financial Stake in Dialysis?
Joint ventures between nephrologists and dialysis centers have expanded treatment. Critics ask: At what cost?
America on Dialysis
Kidney disease affects millions of Americans, but corporate capture of dialysis, along with disparities in treatment and transplant access, mean that not everyone's journey is the same...
Kidney Dialysis Is a Booming Business—Is It Also a Rigged One?
A new California law aims to curb what sponsors say is profiteering by dialysis centers. But are there any easy answers?
These Drugs Might Prevent Severe COVID
Even with vaccines on the way, treatments are needed to prevent the disease from getting worse—and to be ready for COVID-25, COVID-37, and so on
